SmarterDividends
JHPC

Jiangsu Hengrui Pharmaceuticals Co.,Ltd

JHPCY

Healthcare · Stock · annual payer

$11.50

Overvalued · -54% Add to Portfolio

Forward Yield

0.51%

Annual Dividend

$0.06

Payout Ratio

17%

5-Yr Growth

Ex-Date

Apr 30, 2026

Frequency

Annual

Summary

As of September 2026, Jiangsu Hengrui Pharmaceuticals Co.,Ltd (JHPCY) yields 0.51% ($0.06 per share annually), with a blended fair-value estimate of $5.29 — -54% downside, so it screens as overvalued.

Is JHPCY a good dividend stock?

Mixed

Jiangsu Hengrui Pharmaceuticals Co.,Ltd (JHPCY) pays a annual dividend yielding 0.51% ($0.06/yr), with 0 years of growth. The picture is mixed — the dividend pays, but safety or growth signals are weaker than ideal.

Advantages

  • Never cut its dividend on record
  • Comfortable payout ratio (17%)

Risks

  • Single-stock concentration risk — diversify

Key Data

Dividend Yield
0.51%
Payout Ratio
17%
Annual Dividend
$0.06
5-Yr Avg Growth
Ex-Dividend Date
Apr 30, 2026
Years of Growth
0
Frequency
annual
Beta
Market Cap
$38.2B
P/E Ratio
32.9
5-Yr Total Return
52-Week Range
$11.50 – $20.00
Dividend Safety
Ever Cut?
No
JHPCY ex-dividend date & scheduleNext ex-date Apr 30, 2026 · full ex-dividend historyView →

Frequently Asked Questions